HUMA - Humacyte - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HUMA is currently covered by 5 analysts with an average price target of $9.97. This is a potential upside of $5.85 (141.99%) from yesterday's end of day stock price of $4.12.

Humacyte's activity chart (see below) currently has 14 price targets and 35 ratings on display. The stock rating distribution of HUMA is 96% BUY and 4% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.79% with an average time for these price targets to be met of 194.5 days.

Highest price target for HUMA is $17, Lowest price target is $10, average price target is $9.97.

Most recent stock forecast was given by BRUCE JACKSON from BENCHMARK on 23-Dec-2024. First documented stock forecast 20-Jul-2021.

Currently out of the existing stock ratings of HUMA, 24 are a BUY (96%), 1 are a HOLD (4%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$17

$12.39 (268.76%)

$15

22 days ago
(23-Dec-2024)

0/13 (0%)

$12.65 (290.80%)

Buy

$10

$5.39 (116.92%)

$5

2 months 27 days ago
(18-Oct-2024)

1/4 (25%)

$4.97 (98.81%)

511

Buy

$10

$5.39 (116.92%)

$11

2 months 27 days ago
(18-Oct-2024)

1/6 (16.67%)

$4.97 (98.81%)

430

Buy

$13

$8.39 (182.00%)

$7

3 months 25 days ago
(20-Sep-2024)

6/7 (85.71%)

$7.64 (142.54%)

192

Hold

$3

$-1.61 (-34.92%)

1 years 2 months 4 days ago
(10-Nov-2023)

1/3 (33.33%)

$0.65 (27.66%)

34

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HUMA (Humacyte) average time for price targets to be met?

On average it took 194.5 days on average for the stock forecasts to be realized with a an average price target met ratio 26.79

Which analyst has the current highest performing score on HUMA (Humacyte) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?

BRUCE JACKSON

Which analyst has the most public recommendations on HUMA (Humacyte)?

Kristen Kluska works at CANTOR FITZGERALD and has 19 price targets and 14 ratings on HUMA

Which analyst is the currently most bullish on HUMA (Humacyte)?

Suraj Kalia with highest potential upside - $13.72

Which analyst is the currently most reserved on HUMA (Humacyte)?

Matt O'brien with lowest potential downside - -$1.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?